Extrachromosomal DNA (ecDNA) in cancer pathogenesis

Area of Science:

• Oncology
• Genomics
• Epigenetics

Background:

• Extrachromosomal DNA particles (ecDNAs) are circular DNA elements found outside the main chromosomes in cancer cells.
• They facilitate rapid tumor evolution, genetic heterogeneity, and therapeutic resistance due to high oncogene amplification and altered gene regulation.
• ecDNAs are increasingly recognized as a common feature in aggressive cancers, posing challenges to current treatment paradigms.

Purpose of the Study:

• To review the current understanding of ecDNA formation, biological impact, and clinical significance in cancer.
• To highlight recent advancements in ecDNA research.
• To discuss the potential and challenges of targeting ecDNA in precision oncology.

Main Methods:

• This review synthesizes findings from recent scientific literature on ecDNA.
• It integrates knowledge from cancer genomics, epigenetics, and molecular biology.

Main Results:

• ecDNAs promote oncogene copy number increase and intratumoral genetic diversity.
• Their circular structure enhances chromatin accessibility, leading to massive oncogene transcription and driving tumor growth.
• ecDNA is implicated in accelerated tumor evolution and resistance to therapies.

Conclusions:

• ecDNA represents a critical nexus of cancer genomics and epigenetics, significantly impacting tumor progression.
• Further research into ecDNA biology and therapeutic targeting holds promise for novel cancer treatment strategies.
• Addressing the challenges posed by ecDNA is essential for improving outcomes in aggressive cancers.